Regional Health director granted 3,000 stock options

Regional Health Properties, Inc. director Gene E. Burleson was granted 3,000 non-qualified stock options on January 16, 2026.

Rhea-AI Filing Summary

Regional Health Properties, Inc. director Gene E. Burleson was granted 3,000 non-qualified stock options on January 16, 2026. The options have an exercise price of $1.30 per share, based on the average of that day’s high and low OTC prices, and vest immediately.

The options, granted under Regional Health Properties’ Amended and Restated 2023 Omnibus Incentive Compensation Plan, are exercisable into 3,000 shares of common stock until January 16, 2036. Following this grant, Burleson directly holds 3,000 derivative securities in the form of these stock options.

Insider Trade Summary

Grant/Award: 3,000 shares

Grant/Award 1 txn

Insider BURLESON GENE E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Non-Qualified Stock Option (right to buy)	3,000	$0.00	$0.00

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 3,000 contracts (Direct)

Footnotes (3)

1. F1. Non-qualified stock options granted pursuant to the Regional Health Properties, Inc.'s Amended and Restated 2023 Omnibus Incentive Compensation Plan.
2. F2. Based on the average of the high/low of Regional Health Properties, Inc. common stock on the OTC market on January 16, 2026.
3. F3. The non-qualified stock options vest immediately.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Regional Health Properties (RHEP) latest Form 4 report?

The filing reports that director Gene E. Burleson received 3,000 non-qualified stock options on January 16, 2026. These options were granted under the company’s Amended and Restated 2023 Omnibus Incentive Compensation Plan and are exercisable for common stock at a set exercise price.

How many stock options were granted to Gene E. Burleson at RHEP?

Gene E. Burleson was granted 3,000 non-qualified stock options. Each option gives the right to buy one share of Regional Health Properties common stock, providing equity-based compensation tied directly to the company’s share performance over the life of the option grant.

What is the exercise price of Gene Burleson’s Regional Health (RHEP) stock options?

The options have a $1.30 per share exercise price. This price was calculated using the average of the high and low trading prices of Regional Health Properties common stock on the OTC market on January 16, 2026, the grant date of the award.

When do Gene Burleson’s Regional Health (RHEP) options vest and expire?

The non-qualified stock options vest immediately on the January 16, 2026 grant date. They remain exercisable until January 16, 2036, giving Burleson a ten-year window to purchase Regional Health Properties common shares under the terms of the award.

Under which plan were the Regional Health (RHEP) options to Gene Burleson granted?

The 3,000 non-qualified stock options were granted under Regional Health Properties, Inc.’s Amended and Restated 2023 Omnibus Incentive Compensation Plan. This plan authorizes equity-based awards, such as stock options, to directors and other eligible participants of the company.

What is Gene Burleson’s ownership status after this RHEP option grant?

After the transaction, Gene E. Burleson beneficially owns 3,000 derivative securities in the form of non-qualified stock options. The filing lists this as direct ownership, reflecting his personal right to exercise these options into Regional Health Properties common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/09/2026 - 07:11 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BURLESON GENE E

(Last) (First) (Middle)

C/O REGIONAL HEALTH PROPERTIES, INC

1050 CROWN POINTE PARKWAY SUITE 720

(Street)

ATLANTA GA 30338

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
REGIONAL HEALTH PROPERTIES, INC [ RHEP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/16/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)(1)	$1.3(2)	01/16/2026		A		3,000		01/16/2026(3)	01/16/2036	Common Stock	3,000	$0	3,000	D

Explanation of Responses:

1. Non-qualified stock options granted pursuant to the Regional Health Properties, Inc.'s Amended and Restated 2023 Omnibus Incentive Compensation Plan.

2. Based on the average of the high/low of Regional Health Properties, Inc. common stock on the OTC market on January 16, 2026.

3. The non-qualified stock options vest immediately.

	/s/ Gene E. Burleson	02/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.